This trial is enrolling 15 individuals with chronic complete thoracic spinal cord injuries to test the effect of a cell therapy called Stromal Vascular Fraction (SVF) combined with a structural support by way of functional self-assembling peptide nanofiber hydrogels. If included, participants will undergo surgery with implantation of SVF and hydrogel material. Final testing for walking and other functions will be performed after 12 months.
Traumatic
Type
Details
- Participants will undergo spinal surgery that includes implantation of Stromal Vascular Fraction (SVF) and functional self-assembling peptide nanofiber hydrogels at the site of injury. - SVF is a heterogeneous mixture of cells obtained from adipose (fat) tissue. - Hydrogels can support 3D stem cell growth and may promote neural regeneration. - Final testing will be performed after 12 months.
Main benefits
Standing/walking/mobility
Additional benefits
Sexual health
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn moreWings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more